跳至主要内容
临床试验/NCT05396261
NCT05396261已完成不适用

Post-marketing Surveillance of a Flexible Wound Dressing for the Management of Genital Skin Conditions

Stratpharma AG1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2018年1月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
54
试验地点
1
主要终点
gynaecological skin condition

研究概览

简要总结

The objective of the study is to determine the efficacy of 7-0940 in the management of genital skin conditions in female patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •Able to provide informed consent
  • •Diagnosed genital skin condition

排除标准

  • •Unable to give informed consent
  • •Patient unable to apply topical device
  • •Allergy or intolerance to ingredients or excipients of the formulation of studied products

研究组 & 干预措施

Treatment arm

Experimental

Film forming silicone gel (7-0940) is an innovative gel that forms a full contact, flexible wound dressing for supporting mucosal conditions of the genital, rectal and perineal areas.

Film forming silicone gel (7-0940) is a semi-occlusive, non-resorbable, self-drying and transparent gel.

Film forming silicone gel (7-0940) may be directly applied to dry, wet, cracked and sensitive mucosal tissue.

Film forming silicone gel (7-0940) gel is bacteriostatic and inert. It contains no alcohols, parabens or fragrances.

干预措施: Film forming silicone gel (7-0940) (Device)

结局指标

主要结局

gynaecological skin condition

时间窗: Duration of the therapy will be according to physician's clinical practice. The average is 3 visits over a period of 3 to 6 months

Likert scales to measure: * Dryness * Tissue thinning * Erosion/Ulcers * Fissures * Erythema * Scarring/adhesion * Contact bleeding * Bloodblisters * Greyish film * White lacy streaks

次要结局

  • patient symptoms(Duration of the therapy will be according to physician's clinical practice. The average is 3 visits over a period of 3 to 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验